Your browser doesn't support javascript.
loading
Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors.
Joo, Young Su; Rim, Tyler Hyungtaek; Koh, Hee Byung; Yi, Joseph; Kim, Hyeonmin; Lee, Geunyoung; Kim, Young Ah; Kang, Shin-Wook; Kim, Sung Soo; Park, Jung Tak.
Affiliation
  • Joo YS; Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.
  • Rim TH; Division of Nephrology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
  • Koh HB; Mediwhale Inc, Seoul, Republic of Korea. tyler.rim.academia@gmail.com.
  • Yi J; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore. tyler.rim.academia@gmail.com.
  • Kim H; Ophthalmology and Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore, Singapore. tyler.rim.academia@gmail.com.
  • Lee G; Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.
  • Kim YA; Department of Internal Medicine, International Saint Mary's Hospital, Catholic Kwandong University, Incheon, Republic of Korea.
  • Kang SW; Albert Einstein College of Medicine, New York, USA.
  • Kim SS; Mediwhale Inc, Seoul, Republic of Korea.
  • Park JT; Mediwhale Inc, Seoul, Republic of Korea.
NPJ Digit Med ; 6(1): 114, 2023 Jun 17.
Article in En | MEDLINE | ID: mdl-37330576
ABSTRACT
Despite the importance of preventing chronic kidney disease (CKD), predicting high-risk patients who require active intervention is challenging, especially in people with preserved kidney function. In this study, a predictive risk score for CKD (Reti-CKD score) was derived from a deep learning algorithm using retinal photographs. The performance of the Reti-CKD score was verified using two longitudinal cohorts of the UK Biobank and Korean Diabetic Cohort. Validation was done in people with preserved kidney function, excluding individuals with eGFR <90 mL/min/1.73 m2 or proteinuria at baseline. In the UK Biobank, 720/30,477 (2.4%) participants had CKD events during the 10.8-year follow-up period. In the Korean Diabetic Cohort, 206/5014 (4.1%) had CKD events during the 6.1-year follow-up period. When the validation cohorts were divided into quartiles of Reti-CKD score, the hazard ratios for CKD development were 3.68 (95% Confidence Interval [CI], 2.88-4.41) in the UK Biobank and 9.36 (5.26-16.67) in the Korean Diabetic Cohort in the highest quartile compared to the lowest. The Reti-CKD score, compared to eGFR based methods, showed a superior concordance index for predicting CKD incidence, with a delta of 0.020 (95% CI, 0.011-0.029) in the UK Biobank and 0.024 (95% CI, 0.002-0.046) in the Korean Diabetic Cohort. In people with preserved kidney function, the Reti-CKD score effectively stratifies future CKD risk with greater performance than conventional eGFR-based methods.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: NPJ Digit Med Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: NPJ Digit Med Year: 2023 Document type: Article